NDC product
RelaxInk LIDOCAINE
NDC 83714-0004 · Hambli Limited
Key facts
| Product NDC | 83714-0004 |
|---|---|
| Proprietary name | RelaxInk LIDOCAINE |
| Nonproprietary name | LIDOCAINE 4% |
| Substances | LIDOCAINE |
| Dosage form | CREAM |
| Route | TOPICAL |
| Labeler | Hambli Limited |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M017 |
| Pharmacologic classes | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] |
| Marketing start | Feb 15, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: